{"database": "lobbying", "table": "lobbying_activities", "rows": [[3238183, "6c8769e4-05ab-4b15-8b5c-5aa9b347fd5e", "Q3", "THE VOGEL GROUP", 401104734, "HEALTHCARE SUPPLY CHAIN ASSOCIATION", 2024, "third_quarter", "MAN", "Issues pertaining to group purchasing organizations, including matters related to supply chains in healthcare, drugs and medical devices, drug pricing, and drug shortages; Issues related to incentivizing domestic manufacturing of critical healthcare supplies, including PPE, and the Strategic National Stockpile; Issued related to sustainability in the healthcare sector; Legislation related to drug supply chain management; Education related to differences between group purchasing organizations and pharmacy benefit managers; Legislation related to drug shortages; S.1339 - Pharmacy Benefit Manager Reform Act; Pandemic and All Hazards Preparedness Act reauthorization.", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2024-10-15T13:01:12-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3238183"], "units": {}, "query_ms": 1.420112093910575, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}